Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
124M
-
Number of holders
-
357
-
Total 13F shares, excl. options
-
124M
-
Shares change
-
+6.11M
-
Total reported value, excl. options
-
$6.47B
-
Value change
-
+$331M
-
Put/Call ratio
-
1.55
-
Number of buys
-
192
-
Number of sells
-
-157
-
Price
-
$52.04
Significant Holders of Guardant Health, Inc. - Common Stock (GH) as of Q2 2025
431 filings reported holding GH - Guardant Health, Inc. - Common Stock as of Q2 2025.
Guardant Health, Inc. - Common Stock (GH) has 357 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 124M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (12.2M shares), BlackRock, Inc. (11M shares), Capital International Investors (4.98M shares), BAILLIE GIFFORD & CO (4.81M shares), Deep Track Capital, LP (4.25M shares), Invesco Ltd. (3.56M shares), EVENTIDE ASSET MANAGEMENT, LLC (3.46M shares), CADIAN CAPITAL MANAGEMENT, LP (3.18M shares), CITADEL ADVISORS LLC (2.94M shares), and UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC (2.93M shares).
This table shows the top 357 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.